Future research will build on these results, to further characterize mechanisms by which brain insulin resistance and modifications on IRS1 relate to cerebrovascular disease, including by examining other molecules in the insulin signaling pathway, using different methods of assessment and in other brain tissues, and testing different sets of persons [10, 13, 18]. The gene discussed is INS; the disease is Insulin resistance.